Close this window

Transaction in Own Shares

04/28/2026
RNS Number : 0451C
Fevertree Drinks PLC
28 April 2026
 

28th April 2026                       

Fevertree Drinks plc

("Fever-Tree" or the "Company")

Transaction in Own Shares

 

Fevertree Drinks plc ("Fever-Tree" or the "Company") announces today it has, in accordance with the authority granted by shareholders at its 2025 Annual General Meeting held on 5th June, purchased the following number of ordinary shares of £0.0025 each in the Company (the "Ordinary Shares") through the Company's broker, Investec Bank plc ("Investec") in the period from 20th April to 24th April 2026.

Date

Venue

Volume-weighted average price (p)

Aggregated volume

Lowest price per share (p)

Highest price per share (p)

20 April 2026

XLON

860.1812

           26,797

851.5000

867.0000

21 April 2026

XLON

854.8762

           19,100

843.5000

870.0000

21 April 2026

AIMX

863.0000

           20,795

863.0000

863.0000

22 April 2026

XLON

836.5579

           24,191

829.5000

862.0000

22 April 2026

AIMX

830.5000

           17,809

830.5000

830.5000

23 April 2026

XLON

834.5318

           19,259

820.0000

844.0000

23 April 2026

AIMX

825.0000

           15,000

825.0000

825.0000

24 April 2026

XLON

836.2185

           31,003

828.5000

844.0000

24 April 2026

AIMX

830.0000

           10,000

830.0000

830.0000

 

The Company intends to cancel the purchased shares.

   

Schedule of Purchases - Individual Transactions

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation) (which forms part of domestic UK law by virtue of the European Union (Withdrawal) Act 2018, as amended), a full breakdown of the individual trades made by Investec on behalf of the Company as part of the share buyback programme is attached to this announcement.

 

http://www.rns-pdf.londonstockexchange.com/rns/0451C_1-2026-4-27.pdf

 

This announcement does not constitute, or form part of, an offer or any solicitation of an offer for securities in any jurisdiction.

 

For further information please contact:

 

Investor queries

Steve Nightingale, Director of Investor Relations I steve.nightingale@fever-tree.com I +44 (0)7951 849564

 

Media queries

Oliver Winters, Director of Communications I oliver.winters@fever-tree.com I +44 (0)770 332 9024  

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSBDLFLQZLBBBZ

Multimedia Files:

Close this window